Common Names: official burnet
Scientists identified octyl gallate from L. extract using advanced chromatography techniques. OG showed significant anti-colon cancer effects in cell lines and mouse models by inhibiting proliferation, inducing apoptosis, and suppressing migration. This research presents a promising approach for developing novel colon cancer therapies.
"ZGS II from Sanguisorba officinalis l. shows promise in treating aggressive osteosarcoma, inhibiting growth and metastasis. Potential new therapy for challenging bone cancer."
Researchers investigated the potential of S. officinalis as a treatment for UC, a serious and incurable illness causing bloody stools. Understanding its molecular mechanism and disease basis could lead to improved treatments with fewer side effects.
Scientists have created an optimized extract from Sanguisorba officinalis L. roots that effectively combats viral hemorrhagic septicemia virus in olive flounder, improving their survival and immune response. This extract could be used as an alternative for controlling the virus in fish farms.
A study found that a 95% ethanolic Sweet Orange (SO) extract (SOEE) has potential in inhibiting hepatic steatosis and fibrosis by regulating oxidative stress, fatty acid oxidation, and gut microbiota composition. This could be beneficial for treating non-alcoholic fatty liver disease (NAFLD).
This study investigated the potential of the traditional Chinese medicine DiYu (DY) to improve the sensitivity and overcome drug resistance in colorectal cancer cells. The results could help identify alternative therapies for drug-resistant cancer.
This study explores the history, taxonomy, habitat, bioactive components, and biological activities of the genus . It specifically investigates Scop and its potential chemical composition and biological effects. The research also considers electron microscopy and mentions pests and beneficial insects. This study lays the groundwork for further research on Scop.
Chinese medicine Sanguisorba officinalis L. extract (ESO) accelerates diabetic wound healing by reducing inflammation through blocking NF-κB/NLRP3 signaling pathway. Promising treatment option.